EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 374 filers reported holding EXELIXIS INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $509 | -99.8% | 26,628 | +89.6% | 0.27% | -53.6% |
| Q3 2022 | $220,000 | +4300.0% | 14,044 | +4845.1% | 0.58% | +4346.2% |
| Q2 2022 | $5,000 | +400.0% | 284 | +1190.9% | 0.01% | +1200.0% |
| Q3 2021 | $1,000 | -99.9% | 22 | -99.9% | 0.00% | -99.9% |
| Q2 2021 | $753,000 | +389.0% | 41,348 | +440.4% | 0.76% | +341.9% |
| Q4 2020 | $154,000 | -20.6% | 7,652 | -4.0% | 0.17% | -12.2% |
| Q3 2020 | $194,000 | +19300.0% | 7,972 | +36136.4% | 0.20% | – |
| Q2 2020 | $1,000 | -92.3% | 22 | -97.0% | 0.00% | -100.0% |
| Q1 2020 | $13,000 | -88.6% | 744 | -88.5% | 0.02% | -84.1% |
| Q4 2019 | $114,000 | -82.2% | 6,461 | -80.0% | 0.13% | -68.5% |
| Q3 2019 | $641,000 | +21266.7% | 32,286 | +21140.8% | 0.42% | +20850.0% |
| Q1 2019 | $3,000 | – | 152 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |